Dr. Xu is the Executive Director of Neurosurgery Department Huashan Hospital (East Campus), Vice President of the Asian Congress of Neurological Surgeons (ACNS), Co-Chair of the Anatomy Committee of the World Federation of Neurosurgical Societies (WFNS), Member of the Cerebrovascular Disease Committee of WFNS, Fellow of the World Academy of Neurosurgery (WANS), Registered Overseas Tutor in Italy, Overseas Examiner in Malaysia, Member of the International Academy of Neuroanatomy (IANA), Founding Member of the Yasargil Neurosurgical Academy, Member of multiple national professional societies (e.g., Chinese Medical Doctor Association), and Reviewer for several international neurosurgical journals.
Specializes in the precise diagnosis and treatment of cerebral and spinal vascular diseases, with world-leading expertise in high-difficulty EC-IC bypass surgery. Pioneered the application of “EC-IC bypass combined with internal carotid artery occlusion” in the treatment of skull base malignant tumors in China, expanding the new pathway for combined diagnosis and treatment of cerebrovascular diseases and tumors. For Moyamoya Disease patients (asymptomatic, ischemic, hemorrhagic subtypes), he develops individualized plans (including preventive surgery and long-term post-operative follow-up) to reconstruct cerebral blood flow, significantly reducing the risk of stroke and improving long-term prognosis.
He is proficient in integrating microsurgery with neurointervention: for complex cases (e.g., multiple aneurysms, giant paraclinoid aneurysms), he combines endovascular embolization with craniotomy to achieve “minimally invasive + precise” dual efficacy.
Dr. Xu has over 30 years of focused experience in clinical practice and research of neurosurgery, particularly in cerebral and spinal vascular diseases. He leads a core team at Huashan Hospital, with his EC-IC bypass technology ranking among the global top tier. His main research focuses include:
From 2002 to 2003, he pursued postdoctoral research in the Department of Neurosurgery at the University of California, San Francisco (UCSF) Medical Center in the United States. In 2008, he furthered his studies at the Neurointervention Center of Rothchild Hospital in Paris, France, under the guidance of Prof. Moret, a world-renowned expert in neurointervention. In 2011, he received training at the University of Helsinki Central Hospital in Finland, learning from Prof. Juha Hernesniemi, a global leader in the field of microsurgery. During this period, he was not only invited to deliver special lectures and conduct surgical video demonstrations on Moyamoya Disease treatment but also later served as a full-time microsurgical anastomosis tutor for Prof. Hernesniemi’s doctoral team, contributing to the cultivation of international microsurgery talents.
Neuro surgery Expert
Cerebral & Spinal Vascular Diseases
EC-IC Bypass Surgery
Moyamoya Disease
Specializes in the precise diagnosis and treatment of cerebral and spinal vascular diseases, with world-leading expertise in high-difficulty EC-IC bypass surgery. Pioneered the application of “EC-IC bypass combined with internal carotid artery occlusion” in the treatment of skull base malignant tumors in China, expanding the new pathway for combined diagnosis and treatment of cerebrovascular diseases and tumors. For Moyamoya Disease patients (asymptomatic, ischemic, hemorrhagic subtypes), he develops individualized plans (including preventive surgery and long-term post-operative follow-up) to reconstruct cerebral blood flow, significantly reducing the risk of stroke and improving long-term prognosis.
He is proficient in integrating microsurgery with neurointervention: for complex cases (e.g., multiple aneurysms, giant paraclinoid aneurysms), he combines endovascular embolization with craniotomy to achieve “minimally invasive + precise” dual efficacy.
Dr. Xu has over 30 years of focused experience in clinical practice and research of neurosurgery, particularly in cerebral and spinal vascular diseases. He leads a core team at Huashan Hospital, with his EC-IC bypass technology ranking among the global top tier. His main research focuses include:
From 2002 to 2003, he pursued postdoctoral research in the Department of Neurosurgery at the University of California, San Francisco (UCSF) Medical Center in the United States. In 2008, he furthered his studies at the Neurointervention Center of Rothchild Hospital in Paris, France, under the guidance of Prof. Moret, a world-renowned expert in neurointervention. In 2011, he received training at the University of Helsinki Central Hospital in Finland, learning from Prof. Juha Hernesniemi, a global leader in the field of microsurgery. During this period, he was not only invited to deliver special lectures and conduct surgical video demonstrations on Moyamoya Disease treatment but also later served as a full-time microsurgical anastomosis tutor for Prof. Hernesniemi’s doctoral team, contributing to the cultivation of international microsurgery talents.
Third Prize of the 10th Shanghai Medical Science and Technology Award
Leader of 2 National Natural Science Foundation of China (NSFC) General Programs
"Outstanding Reviewer" for Neurosurgery and Journal of Neurosurgery (2021–2023)
Second Prize of the National Science and Technology Progress Award
First Prize of the Ministry of Education Science and Technology Progress Award
Zhu, A.P.J., Xu, B. Artificial Intelligence (AI) in Neurosurgery. In: Ammar, A. (eds) Learning and Career Development in Neurosurgery. Springer, Cham. 2022.
Condition Description:
Condition Description:
Condition Description:
Condition Description:
Condition Description:
Condition Description:
Condition Description:
Condition Description:
Condition Description:
Condition Description:
Condition Description:
Condition Description:
We would love to speak with you.
Feel free to reach out using the below details.
Fill out the form below!
We would love to speak with you.
Feel free to reach out using the below details.